A framework of Microbial Genomic Database for clinical metagenomic pathogen diagnosis: development and multi-cohort evaluation
In brief
Clinical pathogen database matched reference detection in 91% of six cohorts
The curated database matched the standard nucleotide reference's pathogen detection in 91% of results across six published cohorts, with closely correlated read counts in 30 retrospective samples. It also reduced erroneous assignments overall, but closely related organisms such as E. coli and Shigella can remain hard to distinguish; prospective multicenter studies must establish its clinical value.
- Journal
- Frontiers in cellular and infection microbiology (Q1)
- Published
- 16 September 2026
- Study design
- Prospective / inception cohort
- Evidence level
- Level 2, Moderate (CEBM 2b)
- Authors
- Han Xia, Yanhua Wen, Xuming Li, Long Hu, Yaqi Yuan, Juanjuan Tian, et al.
- PMID
- 42818648
- DOI
- 10.3389/fcimb.2026.1938149
Why clinicians should know about it
- Picked for Microbiology (medical) (paper of the day, 3 October 2026): CMGD improves clinical metagenomic pathogen detection performance
Abstract
INTRODUCTION: Clinical metagenomic next-generation sequencing (mNGS) enables broad, untargeted pathogen detection, but its analytical performance depends on host depletion strategy, reference database composition, and alignment methodology. We developed the Clinical Microbial Genomic Database (CMGD), a clinically focused reference resource prioritizing medically relevant taxa. METHODS: CMGD was manually curated, clinically stratified, and included more than 18,000 microbial species. We evaluated host-depletion references, alignment and classification strategies, six published clinical cohorts, and 30 retrospective mNGS-positive clinical samples. RESULTS: The combined GRCh38-T2T reference achieved the highest human-read depletion rate while minimizing microbial-read loss. CMGD provided broader target-species coverage than the standard Kraken2 database, and BWA-CMGD showed lower erroneous assignment rates overall, although Kraken2 yielded higher unique species-level assignment rates for many shared taxa. Across six published clinical cohorts, CMGD achieved 91.0% detection concordance with BLAST-NT and a strong read-count correlation (R2 = 0.97). In 30 retrospective samples, CMGD and NT showed strong correlations for total mapped reads (R2 = 0.99) and uniquely mapped reads (R2 = 0.89), with concordance correlation coefficients of 0.99 and 0.92, respectively. High sequence-mapping accuracy did not ensure reliable species-level discrimination for highly homologous taxa such as Escherichia coli and Shigella flexneri. DISCUSSION: Clinically stratified database curation improves the analytical performance, computational efficiency, and interpretability of mNGS-based pathogen detection. Species-complex-level reporting may be more appropriate when species-level discriminatory evidence is insufficient. Prospective multicenter validation is required to establish clinical diagnostic utility.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.